Berry Oncology is based in Beijing, China. It has raised $309M in total funding. Latest round: Series B.
Berry Oncology is based in Beijing, China. Berry Oncology has raised $309M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in August 2021. The round record for Berry Oncology runs through 2021; nothing later has been disclosed. Investors on record include China Merchants Capital Management Co., Ltd., Qiming Venture Partners, Legend Capital, Zhongjin Qichen Industry Equity Investment Fund, E Fund, Fujian Venture Investment Management Co., Ltd. and 3 others. 9 distinct backers are named across the disclosed rounds.
Every Berry Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Beijing at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026